Bank of New York Mellon Corp - TALIS BIOMEDICAL CORP ownership

Back to all holdings Add to watchlist

TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 48 filers reported holding TALIS BIOMEDICAL CORP in Q4 2021. The put-call ratio across all filers is 2.03 and the average weighting 0.0%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of TALIS BIOMEDICAL CORP
ValueSharesWeighting
Q1 2022$74,000
-66.2%
52,462
-3.8%
0.00%–
Q4 2021$219,000
-60.2%
54,546
-37.9%
0.00%–
Q3 2021$550,000
-41.4%
87,846
+3.4%
0.00%–
Q2 2021$938,000
-8.8%
84,983
+6.3%
0.00%–
Q1 2021$1,028,000–79,941–0.00%–
 Download
Other shareholders

There were no reported owners of TALIS BIOMEDICAL CORP in Q4 2021.

NameSharesValueWeighting ↓
View complete list of TALIS BIOMEDICAL CORP shareholders